Chempro Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 0.12 M
- Company Age 16 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
- Satisfied Charges ₹ 3.00 Cr
- Revenue Growth -4.73%
- Profit Growth -32.01%
- Ebitda -26.30%
- Net Worth 5.54%
- Total Assets -20.75%
About Chempro Pharma
Chempro Pharma Private Limited (CPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 17 May 2008 and has a history of 16 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.12 M.
The company currently has active open charges totaling ₹2.00 Cr. The company has closed loans amounting to ₹3.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Arun Sehgal, Vijay Agarwal, Vandan Agarwal, and One other member serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24230MH2008PTC182363
-
Company No.
182363
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 May 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Chempro Pharma Private Limited offer?
Chempro Pharma Private Limited offers a wide range of products and services, including Ferro Alloys, High Carbon Ferrochrome, Ferro Vanadium, Ferro Molybdenum, Ferro Manganese, Silico Manganese, High Carbon Ferro Manganese.
Who are the key members and board of directors at Chempro Pharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Sehgal
|
Director | 17-May-2008 | Current |
|
Vijay Agarwal
|
Director | 17-May-2008 | Current |
|
Vandan Agarwal
|
Director | 03-Apr-2023 | Current |
|
Deepkiran Khanwalkar
|
Director | 18-Dec-2009 | Current |
Financial Performance of Chempro Pharma.
Chempro Pharma Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 4.73% decrease. The company also saw a substantial fall in profitability, with a 32.01% decrease in profit. The company's net worth moved up by a moderate rise of 5.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chempro Pharma?
Unlock access to Chempro Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Mahavir Laboratories Private LimitedArun Sehgal and Vijay Agarwal are mutual person
-
Goldstar Chemicals Private LimitedArun Sehgal and Vijay Agarwal are mutual person
-
Jbims Alumni AssociationArun Sehgal is a mutual person
Charges (Loans)
₹2.00 Cr
₹3.00 Cr
Charges Breakdown by Lending Institutions
- Others : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Mar 2017 | Others | ₹2.00 Cr | Open |
| 02 Sep 2013 | Deutsche Bank Ag | ₹3.00 Cr | Satisfied |
How Many Employees Work at Chempro Pharma?
Unlock and access historical data on people associated with Chempro Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chempro Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chempro Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
